Showing results (71-80 of 85) with videos related to
Sort By:
Pageof 9
Molecular Endocrinology (Baltimore, Md.)|December 20, 2012
Targeting thymic epithelia AR enhances T-cell reconstitution and bone marrow transplant grafting efficacyKuo-Pao Lai, Jiann-Jyh Lai, Philip Chang, et al.Academic Radiology|July 27, 2012
Comparison of the sensitivity of a pre-MRI questionnaire and point of care eGFR testing for detection of impaired renal functionPhilip Chang, Elise Saddleton, Anne E Laumann, et al.Journal of the National Comprehensive Cancer Network : JNCCN|April 1, 2026
Consensus Recommendations for Disease- and Treatment-Related Fatigue in Patients With Advanced Prostate Cancer: A Modified Delphi PanelStephen J Freedland, William Aronson, Arash Asher, et al.Cancer Research|November 4, 2005
Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathwayJing Ni, Xingqiao Wen, Jorge Yao, et al.World Journal for Pediatric & Congenital Heart Surgery|June 28, 2013
Unoperated congenitally corrected transposition of the great arteries, nonrestrictive ventricular septal defect, and pulmonary stenosis in middle adulthood: do multiple wrongs make a right?Jerold S Shinbane, Jabi Shriki, Antereas Hindoyan, et al.Journal of Burn Care & Research : Official Publication of the American Burn Association|September 7, 2017
Resolvin D2 Limits Secondary Tissue Necrosis After Burn Wounds in RatsYoshitaka Inoue, Yuk Ming Liu, Masayuki Otawara, et al.Nature Communications|June 3, 2020
The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancerKeliang Wang, Jie Luo, Shuyuan Yeh, et al.Journal of Burn Care & Research : Official Publication of the American Burn Association|May 19, 2019
Usefulness of a Novel System for Feedback of Patient-Reported Outcome Measures in Children Recovering From BurnsAlexa Riobueno-Naylor, Stephanie Romo, Lewis Kazis, et al.Science Translational Medicine|May 22, 2024
Preclinical efficacy and pharmacokinetics of an RNA-encoded T cell-engaging bispecific antibody targeting human claudin 6Christiane R Stadler, Ursula Ellinghaus, Leyla Fischer, et al.The Lancet. Respiratory Medicine|February 13, 2021
Long-term safety and efficacy of tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension studyPatrick A Flume, Reta Fischer Biner, Damian G Downey, et al.Pageof 9